NMDAR | CASPR2 | GAD65 | ||||
---|---|---|---|---|---|---|
Cases (n = 21) | Controls (n = 42) | Cases (n = 14) | Controls (n = 28) | Cases (n = 9) | Controls (n = 18) | |
Age, mean (SD) | 48.6 (16.3) | 46.7 (14.2) | 45.0 (16.1) | 43.4 (14.7) | 47.1 (14.0) | 45.8 (11.8) |
Sex, men (%) | 62 | 62 | 71 | 71 | 56 | 56 |
Education, n (%) | ||||||
≤ 9 years | 9 (43) | 20 (48) | 6 (43) | 9 (32) | 4 (44) | 7 (39) |
10–12 years | 7 (33) | 14 (33) | 2 (14) | 13 (46) | 4 (44) | 9 (50) |
> 12 years | 5 (24) | 8 (19) | 6 (43) | 6 (21) | 1 (11) | 2 (11) |
Psychiatric diagnosis, n (%) | ||||||
Substance use disorder (F10–19) | 4 (19) | 7 (17) | 3 (21) | 6 (21) | 2 (22) | 3 (17) |
Psychotic disorder (F20–29) | 1 (6) | 6 (14) | 2 (14) | 6 (21) | 1 (11) | 1 (6) |
Affective disorder (F30–39) | 8 (38) | 20 (48) | 5 (36) | 12 (43) | 3 (33) | 9 (50) |
Other psychiatric disordersa | 8 (38) | 9 (21) | 4 (29) | 4 (14) | 3 (33) | 5 (28) |
Psychopharmacological med. at admission, n (%) | ||||||
Antipsychotic med. | 6 (29) | 13 (31) | 5 (36) | 10 (36) | 3 (33) | 5 (28) |
Antipsychotic dose, mean (SD)b | 482 (422) | 458 (302) | 241 (185) | 324 (170) | 1071 (124) | 469 (276)* |
Antidepressive med. | 8 (38) | 9 (21) | 4 (29) | 8 (29) | 3 (33) | 6 (33) |
Mood stabilizing med. | 3 (14) | 10 (24) | 2 (14) | 4 (14) | 2 (22) | 3 (17) |
No psychopharmacological med. | 10 (48) | 18 (43) | 5 (36) | 12 (43) | 4 (44) | 8 (44) |
Psychopharmacological med. at discharge, n (%) | ||||||
Antipsychotic med. | 9 (43) | 26 (62) | 6 (43) | 18 (64) | 5 (56) | 11 (61) |
Antipsychotic dose, mean (SD)b | 418 (449) | 408 (331) | 222 (203) | 342 (226) | 784 (403) | 331 (254)* |
Antidepressive med. | 9 (43) | 7 (17)* | 4 (29) | 7 (25) | 2 (22) | 6 (33) |
Mood stabilizing med. | 6 (29) | 15 (36) | 5 (36) | 6 (21) | 2 (22) | 5 (28) |
No psychopharmacological med. | 5 (24) | 10 (24) | 3 (21) | 5 (18) | 2 (22) | 5 (28) |
Number of days admitted, mean (SD) | 9.5 (11.4) | 9.9 (9.1) | 9.5 (6.1) | 10.1 (11.6) | 9.6 (9.3) | 9.1 (8.3) |
Alcohol or substance use days/weeks prior to admission, n (%) | 16 (76) | 21 (50)* | 10 (71) | 18 (64) | 7 (78) | 10 (56) |
History of seizuresc | 1 (6) | 9 (25) | 4 (40) | 3 (13) | 2 (22) | 3 (18) |